JMOM:NYE-JPMorgan U.S. Momentum Factor ETF (USD)

ETF | Large Growth |

Last Closing

USD 26.42

Change

+0.86 (+3.37)%

Market Cap

USD 0.05B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-04-08 )

Largest Industry Peers for Large Growth

Symbol Name Price(Change) Market Cap
VUG Vanguard Growth Index Fund ETF..

+0.75 (+0.22%)

USD 117.39B
IWF iShares Russell 1000 Growth ET..

+1.39 (+0.41%)

USD 87.69B
IVW iShares S&P 500 Growth ETF

+0.28 (+0.33%)

USD 42.26B
SCHG Schwab U.S. Large-Cap Growth E..

+0.17 (+0.18%)

USD 23.86B
SPYG SPDR® Portfolio S&P 500 Growt..

+0.23 (+0.31%)

USD 22.11B
MGK Vanguard Mega Cap Growth Index..

+0.60 (+0.21%)

USD 17.22B
IWY iShares Russell Top 200 Growth..

+0.46 (+0.24%)

USD 9.49B
VOOG Vanguard S&P 500 Growth Index ..

+0.73 (+0.24%)

USD 8.39B
SPGP Invesco S&P 500 GARP ETF

+1.56 (+1.50%)

USD 4.59B
JKE iShares Morningstar Growth ETF

N/A

USD 2.06B

ETFs Containing JMOM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Large Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -13.12% 38% F 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -13.12% 38% F 69% C-
Trailing 12 Months  
Capital Gain -4.88% 29% F 73% C
Dividend Return 0.36% 29% F 5% F
Total Return -4.52% 25% F 71% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.74% 75% C 55% F
Dividend Return 4.23% 72% C 40% F
Total Return 0.49% 35% F 13% F
Risk Return Profile  
Volatility (Standard Deviation) 8.29% 57% F 86% B+
Risk Adjusted Return 51.06% 73% C 58% F
Market Capitalization 0.05B 21% F 20% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.